Hep C Elimination Falling Behind

A Story of Mixed Success

The newly released 2022 annual report from the Burnet and Kirby institutes, Australia’s Progress Towards Hepatitis C Elimination, has a story of mixed success to tell.

Unrestricted access to direct-acting antivirals (DAAs) through public subsidy since March 2016 means there is a real opportunity to reach the official government target of eliminating hepatitis C as a public health threat in Australia by 2030.

Continue reading “Hep C Elimination Falling Behind”

Hepatitis C – Australia likely to miss targets

Despite having been one of the countries leading in the global campaign to eliminate viral hepatitis, Australia may now not meet its 2022 national hepatitis C treatment target or the 2030 global target.

Continue reading “Hepatitis C – Australia likely to miss targets”

Hepatitis B Targets – Australia 23 years behind on care, 24 on treatment

Australia still has a long way to go to achieve its National Hepatitis B Strategy targets aimed at eliminating the disease by 2030.

Continue reading “Hepatitis B Targets – Australia 23 years behind on care, 24 on treatment”